Holen Sie sich die Stockscreener-App
1.22
16.19%
0.17
Handel nachbörslich:
1.24
0.02
+1.64%
Schlusskurs vom Vortag:
$1.05
Offen:
$1.06
24-Stunden-Volumen:
3.92M
Relative Volume:
3.31
Marktkapitalisierung:
$167.42M
Einnahmen:
$4.35M
Nettoeinkommen (Verlust:
$-45.53M
KGV:
-1.1296
EPS:
-1.08
Netto-Cashflow:
$-44.79M
1W Leistung:
+19.61%
1M Leistung:
-0.41%
6M Leistung:
-24.69%
1J Leistung:
+52.25%
1-Tages-Spanne:
$1.055
$1.23
1-Wochen-Bereich:
$1.01
$1.23
52-Wochen-Spanne:
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Firmenname
Lucid Diagnostics Inc
Sektor
Branche
Telefon
212 949 4319
Adresse
360 MADISON AVENUE, NEW YORK
Vergleichen Sie LUCD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.22 | 106.99M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
134.27 | 231.52B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
375.29 | 141.16B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
BSX
Boston Scientific Corp
|
96.79 | 142.10B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
MDT
Medtronic Plc
|
97.87 | 126.13B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.74 | 45.04B | 5.69B | 1.41B | 577.90M | 6.9828 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-12-27 | Eingeleitet | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Eingeleitet | BTIG Research | Buy |
| 2021-11-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Eingeleitet | Needham | Buy |
Lucid Diagnostics Inc Aktie (LUCD) Neueste Nachrichten
PAVmed subsidiary Veris Health launches cancer care platform at OSU center - Investing.com Nigeria
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Will Lucid Diagnostics Inc. stock benefit from automationMarket Weekly Review & Verified Chart Pattern Trade Signals - newser.com
Can Lucid Diagnostics Inc. stock beat analyst upgradesWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
What sentiment indicators say about Lucid Diagnostics Inc. stockJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
What recovery options are there for Lucid Diagnostics Inc.Weekly Market Report & Reliable Price Breakout Signals - newser.com
Reversal indicators forming on Lucid Diagnostics Inc. stockInsider Selling & Consistent Profit Alerts - newser.com
Will a bounce in Lucid Diagnostics Inc. offer an exit2025 Top Gainers & Trade Opportunity Analysis - newser.com
Identifying reversal signals in Lucid Diagnostics Inc.Earnings Trend Report & Daily Technical Forecast Reports - newser.com
Earnings visualization tools for Lucid Diagnostics Inc.2025 Geopolitical Influence & Expert-Curated Trade Recommendations - newser.com
Tick level data insight on Lucid Diagnostics Inc. volatilityTrade Performance Summary & AI Driven Stock Reports - newser.com
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) PT at $3.65 - Defense World
Altoona firefighters receive cancer screenings - WJAC
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Published on: 2025-09-29 09:04:08 - newser.com
Lucid Diagnostics: Holding Onto Medicare Coverage Hopes (NASDAQ:LUCD) - Seeking Alpha
Published on: 2025-09-29 01:30:08 - newser.com
What analysts say about Lucid Diagnostics Inc stockTrendline Breakouts & Low Cost Capital Growth - earlytimes.in
Lucid Diagnostics (NASDAQ:LUCD) Rating Increased to Hold at Wall Street Zen - MarketBeat
Published on: 2025-09-27 23:30:42 - newser.com
Lucid Diagnostics Appoints John R. Palumbo to Board - The Globe and Mail
Lucid Diagnostics appoints healthcare veteran John Palumbo to board By Investing.com - Investing.com Nigeria
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors, Effective Date Is September 22, 2025 - MarketScreener
Lucid Diagnostics Appoints John R. Palumbo To Board - citybiz
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. P - GuruFocus
Lucid Diagnostics appoints healthcare veteran John Palumbo to board - Investing.com India
Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors - PR Newswire
Lucid Diagnostics (NASDAQ:LUCD) Cut to "Sell" at Wall Street Zen - MarketBeat
How to build a dashboard for Lucid Diagnostics Inc. stockEarnings Beat & Safe Swing Trade Setups - newser.com
Finanzdaten der Lucid Diagnostics Inc-Aktie (LUCD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
1.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):